Brooks Laboratories Limited (BROOKS.NS) Stock Overview
Explore Brooks Laboratories Limited’s financial performance, market position, analyst ratings, and future outlook.
Brooks Laboratories Limited (BROOKS.NS)
Key Financials
Key Financials
Market Cap
2B
P/E Ratio
15.62
EPS (TTM)
$4.49
ROE
0.11%
BROOKS.NS Stock Analysis & Investment Overview (NSE)
Our AI-powered analysis of Brooks Laboratories Limited (NSE: BROOKS.NS) gives investors deep insight into how the stock performs on the NSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Brooks Laboratories Limited's NSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BROOKS.NS on the NSE shows an RSI of 66.60, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $79.27 for the NSE listing.
Key metrics behind Brooks Laboratories Limited's NSE-traded stock include a P/E ratio of 15.62 and a market capitalization of 2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BROOKS.NS on the NSE.